Lyle DA, Lopez A, Osofsky R, Wiemann B, Boyd N, Olson G, Rana MA. Outcomes of Carotid Body Tumor Management with Active Surveillance.
Ann Otol Rhinol Laryngol 2022;
132:551-557. [PMID:
35723203 DOI:
10.1177/00034894221105833]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
OBJECTIVES
To assess outcomes of carotid body tumors (CBTs) managed with active surveillance.
METHODS
Retrospective chart review of CBTs managed with active surveillance from 2001 to 2019.
RESULTS
A total of 115 cases were identified during chart review. Sixty-five of these patients were managed with active surveillance, and 11 patients had bilateral tumors for a total of 76 tumors. Follow-up records with symptomatic outcomes were available for 51 patients, and 47 tumors had follow-up imaging. Thirty-one (66%) actively surveilled CBTs remained stable or decreased in size while 16 (34%) increased in size. Patients undergoing active surveillance developed symptoms in 12 cases, 6 of these patients underwent surgical intervention. Nine CBTs managed with active surveillance (18%) were ultimately resected. The majority of patients who did not undergo surgical intervention never developed symptoms (36/42, 86%).
CONCLUSIONS
Active surveillance may be a reasonable approach for a subset of CBTs.
Collapse